BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12038299)

  • 1. Pulmonary hypertension and HIV.
    Proj Inf Perspect; 2002 Mar; (34):12-3. PubMed ID: 12038299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-related pulmonary arterial hypertension: clinical presentation and management.
    Sitbon O
    AIDS; 2008 Sep; 22 Suppl 3():S55-62. PubMed ID: 18845923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin for HIV-associated pulmonary hypertension.
    Stricker H; Domenighetti G; Mombelli G
    Ann Intern Med; 1997 Dec; 127(11):1043. PubMed ID: 9412295
    [No Abstract]   [Full Text] [Related]  

  • 4. Pulmonary hypertension associated with HIV infection.
    Seoane L; Shellito J; Welsh D; de Boisblanc BP
    South Med J; 2001 Jun; 94(6):635-9. PubMed ID: 11440333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curing HIV-associated pulmonary arterial hypertension.
    Tcherakian C; Rivaud E; Zucman D; Metivier AC; Couderc LJ
    Eur Respir J; 2012 Apr; 39(4):1045-6. PubMed ID: 22467729
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV-associated pulmonary hypertension.
    Farber HW
    AIDS Clin Care; 2001 Jun; 13(6):53-5, 59. PubMed ID: 11710309
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of severe pulmonary hypertension with prostacyclin and iloprost].
    Matthes J; Mathen F; Herzig S; Wassermann K
    Dtsch Med Wochenschr; 2001 May; 126(21):631-7. PubMed ID: 11413752
    [No Abstract]   [Full Text] [Related]  

  • 8. Highly active antiretroviral therapy compared with HAART and bosentan in combination in patients with HIV-associated pulmonary hypertension.
    Barbaro G; Lucchini A; Pellicelli AM; Grisorio B; Giancaspro G; Barbarini G
    Heart; 2006 Aug; 92(8):1164-6. PubMed ID: 16844879
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhaled epoprostenol.
    Lusardi P; Brown V
    Am J Nurs; 2003 Jul; 103(7):64AA, 64CC, 64EE, 64GG-64HH. PubMed ID: 12865644
    [No Abstract]   [Full Text] [Related]  

  • 10. Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension.
    Sitbon O; Gressin V; Speich R; Macdonald PS; Opravil M; Cooper DA; Fourme T; Humbert M; Delfraissy JF; Simonneau G
    Am J Respir Crit Care Med; 2004 Dec; 170(11):1212-7. PubMed ID: 15317666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-associated pulmonary arterial hypertension: from bedside to the future.
    Correale M; Palmiotti GA; Lo Storto MM; Montrone D; Foschino Barbaro MP; Di Biase M; Lacedonia D
    Eur J Clin Invest; 2015 May; 45(5):515-28. PubMed ID: 25715739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2.
    Humbert M; Barst RJ; Robbins IM; Channick RN; Galiè N; Boonstra A; Rubin LJ; Horn EM; Manes A; Simonneau G
    Eur Respir J; 2004 Sep; 24(3):353-9. PubMed ID: 15358690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
    Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
    J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter by Dias et al regarding article, "Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy".
    Dias B; Jardim C; Souza R
    Circulation; 2010 Jul; 122(1):e1. PubMed ID: 20606126
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of pulmonary artery hypertension].
    Olschewski H; Seeger W
    Pneumologie; 2000 Jun; 54(6):222-4. PubMed ID: 10934891
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical & surgical approaches to pulmonary hypertension.
    McLaughlin VV; Rich S
    Compr Ther; 1997 Sep; 23(9):612-6. PubMed ID: 9285162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: an observational study.
    Kemp K; Savale L; O'Callaghan DS; Jaïs X; Montani D; Humbert M; Simonneau G; Sitbon O
    J Heart Lung Transplant; 2012 Feb; 31(2):150-8. PubMed ID: 22138355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pulmonary hypertension].
    Kovacs G; Olschewski H
    Dtsch Med Wochenschr; 2012 Oct; 137(40):2026-8. PubMed ID: 23023615
    [No Abstract]   [Full Text] [Related]  

  • 19. Epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.
    Botney M
    N Engl J Med; 1998 Jun; 338(24):1773-4. PubMed ID: 9625639
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma.
    Farber HW; Graven KK; Kokolski G; Korn JH
    J Rheumatol; 1999 May; 26(5):1195-6. PubMed ID: 10332990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.